Skip to Content

Cefepime Pregnancy and Breastfeeding Warnings

Cefepime is also known as: Maxipime

Medically reviewed on December 8, 2017.

Cefepime Pregnancy Warnings

Cefepime has been assigned to pregnancy category B by the FDA. Animal data failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy. Cefepime should only be given in pregnancy when the need has been clearly established.

See references

Cefepime Breastfeeding Warnings

A nursing infant consuming 1000 mL of human milk per day would receive approximately 0.5 mg of cefepime per day.

Cefepime is excreted in human milk in small amounts. While adverse effects are unlikely, the infant should be monitored closely. Although not specifically listing cefepime, the American Academy of Pediatrics classifies other cephalosporins as compatible with breast-feeding. The manufacturer recommends that caution be used when administering cefepime to nursing women.

See references

References for pregnancy information

  1. Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation. 5th ed." Baltimore, MD: Williams & Wilkins (1998):
  2. "Product Information. Maxipime (cefepime)." Bristol-Myers Squibb, Princeton, NJ.

References for breastfeeding information

  1. "Product Information. Maxipime (cefepime)." Bristol-Myers Squibb, Princeton, NJ.
  2. Briggs GG, Freeman RK, Yaffe SJ.. "Drugs in Pregnancy and Lactation. 5th ed." Baltimore, MD: Williams & Wilkins (1998):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide